Alzheimer's patients experience adverse outcomes, delirium

June 18, 2012, Hebrew SeniorLife Institute for Aging Research

The state of acute confusion and disorientation known as delirium can stem from a serious illness, surgery or infection, and often develops while patients are in the hospital. Now a new study confirms that for patients with Alzheimer's disease, hospitalization and delirium pose a particular risk and can lead to adverse outcomes, including hastened cognitive decline, institutionalization and death.

Led by researchers at Harvard Medical School affiliates Hebrew SeniorLife and Beth Israel Deaconess Medical Center (BIDMC), the study appears in the June 19 on-line issue of the .

"Evidence has shown that older patients with Alzheimer's disease [AD] are much more likely to be hospitalized than other older patients," says lead author Tamara Fong, MD, PhD, assistant scientist in the Aging Brain Center, Institute for Aging Research at Hebrew SeniorLife and Assistant Professor of Neurology at BIDMC. "Because our previous research had found that AD patients experienced a three times faster decline in mental function if they had experienced delirium, we wanted to determine if AD patients who are hospitalized are at greater risk for poor outcomes than AD patients who are not hospitalized, and if there is any additive negative outcome when hospitalized AD patients develop delirium."

The researchers, therefore, analyzed the records of 771 patients over age 65 who were examined between 1991 and 2006 at the Massachusetts Alzheimer's Disease Registry (MADRC), a clinical registry based at Massachusetts General Hospital.

"We looked at patients with and without hospitalizations who were seen at least three times in the MADRC during the study interval period," says Fong.

The authors additionally analyzed data from medical records and other data sources, including Medicare and the Social Security Death Index, to determine outcomes of hospitalization and delirium.

As predicted, their findings showed that in patients with , any hospitalization was associated with increased risks for institutionalization, and death, and for those patients who developed delirium, there was an incremental increase in risk for these adverse outcomes, even after controlling for other cofactors.

"Among the hospitalized Alzheimer's patients, a substantial proportion of risk for adverse outcomes could be attributed to delirium, including 6.2 percent of deaths, 15.2 percent of institutionalization, and 20.6 percent of cognitive decline," says Fong. "The bottom line is that delirium can be a big problem for patients with AD," she adds.

There are, however, effective prevention strategies for delirium for hospitalized elders, notes Fong. These include the Hospital Elder Life Program (HELP), a patient care program designed to prevent delirium by keeping hospitalized older people oriented to their surroundings, meeting their needs for nutrition, fluids and sleep, and keeping them mobile within the limitations of their physical conditions. "Going forward, we plan to conduct formal studies to determine if these types of interventions can help improve outcomes for this vulnerable group of patients," she explains.

Adds senior author Sharon Inouye, MD, PhD, Director of the Institute at HSL, Harvard Medical School Professor of Medicine at BIDMC, "Our confirmation that hospitalization and delirium play important roles in adverse outcomes may ultimately influence care and management of patients with AD.

Interventions to prevent hospitalization and hospital-associated may be appropriate for all with AD. The cost savings to Medicare would be far greater than the amount from current treatment options for AD."

Explore further: Delirium after stroke linked to poorer outcomes for patients

Related Stories

Delirium after stroke linked to poorer outcomes for patients

January 19, 2012
Delirium develops in about 30 percent of patients hospitalized shortly after a stroke and is linked to poorer outcomes, according to a new meta-analysis published in Stroke: Journal of the American Heart Association.

Relief on the way for delirium patients

May 27, 2011
Adults with dementia and delirium may soon have a way to combat their delirium, thanks to a $2.4 million, five-year grant from the National Institutes of Health.

Sleep apnea puts patients at risk for delirium after surgery

March 27, 2012
An anecdotal observation of a possible link between sleep apnea and post-surgical delirium has been measured and confirmed by a team of researchers at the Duke University Medical Center.

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.